Brief: Bio-Rad Q1 Adjusted EPS USD 2.29 Vs. IBES Estimate USD 2.15
07/05/2024 21:15
May 07 (Reuters) - Bio-Rad Q1 net income USD 383.9 million. * Q1 sales USD 610.8 million vs. IBES estimate USD 619.1 million * Q1 EBIT margin 7.3% * Q1 EPS USD 13.45 * Q1 gross margin 53.4%
Recent news on Bio-Rad Laboratories
See all newsBio-Rad Laboratories, Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: Bio-Rad Laboratories On July 31, Initiated Restructuring Plan - SEC Filing
Bio-Rad Q2 revenue beats analyst estimates on clinical diagnostics growth
Brief: Bio-Rad Q2 Net Income USD 371.4 Million
Activist investors make bigger push for campaigns in H1, seek more M&A